ctrl K

Watchlist Price Alert

NeuroBo Pharmaceuticals I... (NRBO)

NASDAQ: NRBO · Real-Time Price · USD

2.36

null (null%)

At close: Nov 27, 2024, 9:00 PM

NeuroBo Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	28K	72K	67K	17K	n/a	n/a	n/a
Gross Profit	n/a	-28K	-72K	-67K	-17K	n/a	n/a	n/a
Operating Income	-15.89M	-19.63M	-15.3M	-29.72M	-20.18M	-22.8M	-33.12M	-14.7M
Interest Income	461K	2.19K	14K	39K	n/a	n/a	n/a	n/a
Pretax Income	-12.47M	-13.97M	-15.28M	-29.68M	-21.31M	-23.64M	-33.41M	-14.59M
Net Income	-12.47M	-6.12M	-15.22M	-29.59M	-22.43M	-23.64M	-33.41M	-14.59M
Selling & General & Admin	6.73M	8.64M	8.75M	7.85M	2.7M	8.49M	10.44M	5.96M
Research & Development	9.16M	2.78M	6.55M	21.87M	17.48M	14.31M	22.69M	8.74M
Other Expenses	n/a	-83K	n/a	-1K	12.15M	-178K	10.44M	n/a
Operating Expenses	15.89M	11.42M	15.3M	29.72M	20.18M	22.8M	33.12M	14.7M
Interest Expense	n/a	2.19M	n/a	39K	22K	654K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	10.38M	n/a
Cost & Expenses	15.89M	11.42M	15.3M	29.72M	20.18M	22.8M	33.12M	14.7M
Income Tax Expense	n/a	-7.85M	-62K	-85K	1.12M	654K	286K	-136.82K
Shares Outstanding (Basic)	5.07M	321.7K	96.43K	67.57K	21.77K	141.71K	13.8K	7.75K
Shares Outstanding (Diluted)	5.07M	321.7K	96.43K	67.57K	21.77K	141.71K	13.8K	7.75K
EPS (Basic)	-2.46	-19.01	-157.85	-437.95	-1.03K	-166.8	-2.42K	-1.88K
EPS (Diluted)	-2.46	-19.01	-157.85	-437.95	-1.03K	-166.8	-2.42K	-1.88K
EBITDA	-15.88M	-11.4M	-15.21M	-29.61M	-21.17M	-15.49M	-33.09M	-14.5M
EBIT	-15.89M	-11.42M	-15.28M	-29.68M	-21.18M	-15.49M	-33.09M	-14.5M
Depreciation & Amortization	7K	28K	72K	67K	17K	6.67M	60K	-17K